Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate.
Regan J, Breitfelder S, Cirillo P, Gilmore T, Graham AG, Hickey E, Klaus B, Madwed J, Moriak M, Moss N, Pargellis C, Pav S, Proto A, Swinamer A, Tong L, Torcellini C.
Regan J, et al. Among authors: proto a.
J Med Chem. 2002 Jul 4;45(14):2994-3008. doi: 10.1021/jm020057r.
J Med Chem. 2002.
PMID: 12086485